The authors respond to "Inconsistencies in the 2017 Canadian Guideline for Opioids for Chronic Noncancer Pain"
- PMID: 28970263
- PMCID: PMC5628038
- DOI: 10.1503/cmaj.733313
The authors respond to "Inconsistencies in the 2017 Canadian Guideline for Opioids for Chronic Noncancer Pain"
Conflict of interest statement
Competing interests: All authors are members of the Steering Committee for the Canadian Guideline for Opioid Therapy and Chronic Noncancer Pain. David Juurlink was a member of the Stakeholder Review Group for the US Centers for Disease Control and Prevention guideline for prescribing opioids for chronic pain. No other competing interests were declared.
Comment on
-
Guideline for opioid therapy and chronic noncancer pain.CMAJ. 2017 May 8;189(18):E659-E666. doi: 10.1503/cmaj.170363. CMAJ. 2017. PMID: 28483845 Free PMC article. No abstract available.
-
Inconsistencies in the 2017 Canadian Guideline for Opioids for Chronic Noncancer Pain.CMAJ. 2017 Oct 2;189(39):E1233. doi: 10.1503/cmaj.733244. CMAJ. 2017. PMID: 28970262 Free PMC article. No abstract available.
References
-
- Howlett K. Opioid panel chair admits conflict-of-interest lapse. Globe and Mail [Toronto]. 2017. May 19 Available: www.theglobeandmail.com/news/national/opioid-panel-chair-admits-conflict... (accessed 2017 June 30).
-
- Gillen C, Haurand M, Kobelt DJ, et al. Affinity, potency and efficacy of tramadol and its metabolites at the cloned human mu-opioid receptor. Naunyn Schmiedebergs Arch Pharmacol 2000;362:116–21. - PubMed
-
- Garg RK, Fulton-Kehoe D, Franklin GM. Patterns of opioid use and risk of opioid overdose death among Medicaid patients. Med Care 2017;55:661–8. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical